Latest Cancer vaccine Stories
DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance
MediVet Biologic’s collaboration with researchers at the University of Kentucky’s College of Medicine has led to a groundbreaking novel animal biologic, K9-ACV: an Autologous Cancer Vaccine
New cutting-edge report “Dendritic Cell Cancer Vaccine Market & Clinical Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
TSX Venture: QPT EDMONTON, Jan. 13, 2015 /PRNewswire/ - Quest PharmaTech Inc.
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company FREDERICK, Md., Jan.
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
SAN DIEGO, Dec. 11, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.